Designer Babies: Rogue Science or Future Option?
By Dolli Player and Alicia Matsuura,
The Daily Universe [Cites CGS' Marcy Darnovsky]
| 02. 18. 2020
In the early 2000s, genome editing seemed like the answer to parents who carried latent genes that could result in birth defects, future illnesses or poor quality of life for their potential children. But the technology was still unrefined and expensive. It seemed like it was too far off in the future — a science-fiction-inspired solution to real-world problems.
It wasn’t until the discovery of the CRISPR-Cas9 combination in 2013 that the conversation among scientists changed from “it’s impossible” to “should it be possible?”
Before being able to grasp the meaning of the term “designer babies,” it’s important to understand the building blocks of the system that makes it possible.
The scientific process of creating these possible “designer babies” is called genome editing. A genome is present in every living organism, and it encodes all the messages and instructions of that organism’s DNA sequence. This sequence makes up the characteristics and functions of that organism. CRISPR-cas9 and genome editing change those sequences, which in turn changes the message and the output of those cells.
In scientific terms, CRISPR, which stands...
Related Articles
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
Image by Mohamed Hassan from Pixabay
It is hard to make predictions, especially about the future, as Yogi Berra, Niels Bohr, and other luminaries have remarked. But there are already signs that the incoming Trump administration may have some difficulty establishing consistent policies about controversial issues concerning human reproduction.
On the one hand, consider “the conservative blueprint for a second Trump administration.”
The notorious Project 2025’s Mandate for Leadership seeks to delete terms such as “reproductive rights” from “every federal...
By Susan Dominus, The New York Times | 11.30.2024
In the days after Daphna Cardinale delivered her second child, she experienced a rare sense of calm and wonder. The feeling was a relief after so much worrying: She and her husband, Alexander, had tried for three years to conceive...
By Christy Santhosh, Reuters | 11.27.2024
Nov 27 (Reuters) - The U.S. Food and Drug Administration is weighing the need for regulatory action on bluebird bio's (BLUE.O), opens new tab gene therapy for a rare neurological disorder, it said on Wednesday, as the agency probes additional...
